THERAKOS EUROPE LIMITED

It is used to relieve the skin symptoms of cutaneous T-cell lymphoma when other treatments are not effective. The drug is used in conjunction with a photopheresis system that uses UV rays to activate the active ingredient and destroy diseased white blood cells.

Dosage form: solution for infusion

ATC: D05BA02